GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aditxt ADTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-28.57%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$3,195

FY2017FY2025

Net income

−$41.7m

FY2017FY2025

Free cash flow

−$25.70bn

FY2017FY2025

Shareholders' equity

$5.6m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$3,195$133,985$645,176$933,715$105,034————
Research and development$3.2m$10.9m$7.1m$7.3m$5.0m$937,966$175,441$525,000—
Operating income−$19.6m−$27.9m−$26.1m−$25.5m−$41.9m−$8.9m−$5.9m−$5.6m−$213,000
Net income−$41.7m−$34.4m−$32.4m−$27.6m−$46.4m−$9.1m−$5.8m−$5.7m−$213,000
Diluted earnings per share-1,115.35-68,892.00—————-3.59-0.52

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$16.5m$32.1m$44.6m$10.7m$16.7m$13.1m$123,532$115,709$25,000
Cash and short-term investments$3.2m$833.0m$97,102$2.8m$7.9m$10.5m$4,090$115,709$25,000
Total liabilities$12.6m$23.9m$28.5m$5.5m$6.5m$2.1m$3.0m$1.7m$84,900
Debt$3.0m$6.9m$18.2m$3.4m$4.7m$1.8m$165,600$163,602—
Shareholders' equity$5.6m$8.3m$16.0m$5.2m$10.2m$11.0m−$2.9m−$1.5m−$59,900
Shares outstanding0m0m—————2m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−$25.69bn−$16.8m−$18.6m−$22.4m−$22.3m−$7.2m−$464,352−$386,263−$386,263
Capital spending−$13.7m−$1−$14,407−$367,079−$1.0m−$170,629−$170,629−$170,629−$170,629
Free cash flow−$25.70bn−$16.8m−$18.6m−$22.8m−$23.3m−$7.4m−$634,981−$556,892−$556,892

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue$12,159$425$748$1,004$1,018$3,175$6,854$44,276
Operating income−$4.4m−$4.7m−$3.1m−$6.2m−$5.6m−$5.7m−$4.7m−$6.0m
Net income−$15.9m−$4.7m−$24.0m−$7.3m−$5.7m−$5.2m−$6.9m−$7.5m
Diluted earnings per share-789.49-125.71-642.93-194.03-152.68-10,453.26-13,881.02-15,099.24
Cash from operations−$4.0m−$9.0m−$2.0m−$2.0m−$11.0m−$6.0m−$2.0m−$2.0m
Total assets$13.9m$16.5m$11.8m$32.7m$31.2m$32.1m$29.8m$28.4m
Cash and short-term investments$268,852$3.2m$163,041$323,679$476,416$833.0m$328,596$91,223
Debt$3.9m$2.7m$5.7m$5.4m$3.8m$6.5m$9.5m$7.3m
Shareholders' equity−$33.3m$5.6m−$7.7m$13.0m$16.6m$8.9m$4.7m$6.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-84.9%——
Operating income-8.4%17.1%—
Net income14.7%35.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings——-688.6-5619.7-32253.2-634356.9
Price to sales0.10.0————

Share price return

Finished calendar years

202520242023202220212020
Return-100%-100%-92%-89%-70%-58%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 27-to-1 reverse split · 18 May 2026
  • 8-to-1 reverse split · 9 Mar 2026
  • 113-to-1 reverse split · 3 Nov 2025
  • 250-to-1 reverse split · 17 Mar 2025
  • 40-to-1 reverse split · 2 Oct 2024
  • 40-to-1 reverse split · 18 Aug 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.